The Clinical Microbiology Laboratory at SMA offers full-service diagnostic testing in bacteriology and molecular epidemiology. Our laboratory provides timely, accurate, and medically relevant results to aid in the evaluation, diagnosis, and treatment of infectious diseases
High-throughput, automated testing that utilizes RT-PCR & detection of antibodies in the blood that are produced by the body in response to SARS-CoV-2 virus or after vaccination
SMA provides cognitive wellness testing to provide personalized medicine for individual improvement. Early diagnosis empowers individuals and families more time to plan.
At SMA, we provide vigorous testing for Viral Targets, Bacterial Targets through various methods including respiratory, gastrointestinal, urinary tests, wounds, and vaginal.
Our Genetic testing identifies changes in chromosomes, genes, or proteins. These results can confirm or rule out a suspected genetic condition or help determine a person’s chance of developing or passing on a genetic disorder.
Our Toxicology department provide SMA clients with drug monitoring expertise for patients in need for prescription medications. This service has expanded to include illicit drug of abuse testing.
SMA Laboratory performs a full range of high quality Anatomic Pathology and Non-Gyn Cytopathology services, including histopathology, liquid-based non-gyn cytology, special stains, and immunohistochemistry.
Our services include all areas of Anatomical and Clinical Pathology, such as Hematology, Chemistry, Serology, Toxicology, Molecular Testing in Microbiology, Genetics of Cancer-Risk, Surgical Pathology and Cytopathology.
| ComprehensiveDx Clear™ | |||
| Test Code: | 1248 | ||
| Test Description | ComprehensiveDx Clear is a comprehensive panel for hereditary breast, ovarian, uterine, colorectal, pancreatic, prostate and melanoma cancers. | ||
| Genes Tested | GENE | ASSOCIATED CANCER(S) | SYNDROME |
| APC | Colorectal, pancreatic and other | Familial Adenomatous Polyposis syndrome, Gardner syndrome, and Turcot syndrome | |
| ATM | Breast, pancreatic | Ataxia-telangiectasia (if both copies of the gene are mutated) | |
| BAP1 | Renal, melanoma, mesothelioma | Familial Melanoma Cancer Syndrome | |
| BARD1 | Breast, ovarian | ||
| BMPR1A | Colorectal, gastric, pancreatic | Juvenile Polyposis syndrome | |
| BRCA1 | Breast, ovarian, pancreatic, prostate, male breast | Hereditary Breast and Ovarian Cancer syndrome | |
| BRCA2 | Breast, ovarian, pancreatic, prostate, male breast, melanoma | Hereditary Breast and Ovarian Cancer syndrome; | |
| Fanconi anemia (if both copies of the gene are mutated) | |||
| BRIP1 | Ovarian, breast | Fanconi anemia (if both copies of the gene are mutated) | |
| CDH1 | Breast, gastric, colorectal | Hereditary Diffuse Gastric Cancer | |
| CDK4 | Melanoma, pancreatic | Familial Melanoma Cancer Syndrome | |
| CDKN2A | Melanoma, pancreatic | Familial Melanoma Cancer Syndrome | |
| CHEK2 | Breast, colorectal | ||
| DICER1 | Lung, kidney, thyroid, ovarian | ||
| EPCAM | Colorectal, gastric, endometrial, ovarian | Lynch (Hereditary non-polyposis colon cancer) syndrome | |
| FANCC | Breast | Fanconi anemia (if both copies of the gene are mutated) | |
| MRE11A | Breast, ovarian | Ataxia-telangiectasia-like Syndrome (if both copies of the gene are mutated) | |
| MSH2 | Colorectal, gastric, endometrial, ovarian | Lynch (Hereditary non-polyposis colon cancer) syndrome | |
| MSH6 | Colorectal, endometrial | Lynch (Hereditary non-polyposis colon cancer) syndrome | |
| MUTYH | Colorectal | MUTYH-associated Polyposis syndrome | |
| NBN | Breast, melanoma, prostate | Nijmegen breakage syndrome (if both copies of the gene are mutated) | |
| PALB2 | Breast, ovarian, pancreatic, male breast | Fanconi anemia (if both copies of the gene are mutated) | |
| PMS2 | Colorectal, endometrial, gastric, ovarian | Lynch (Hereditary non-polyposis colon cancer) syndrome | |
| POLD1 | Colorectal, endometrial | Familial Adenomatous Polyposis syndrome | |
| POLE | Colorectal, gastrointestinal | Familial Adenomatous Polyposis syndrome | |
| PTEN | Breast, uterine, colorectal, thyroid, kidney, melanoma | Cowden Syndrome / PTEN Hamartoma Tumor Syndrome | |
| RAD50 | Ovarian | ||
| RAD51C | Breast, ovarian | Fanconi anemia (if both copies of the gene are mutated) | |
| RAD51D | Breast, ovarian | ||
| SDHA | Gastrointestinal, other | Paragangliomas 5 | |
| SDHB | Gastrointestinal, renal, other | Paraganglioma and gastric stromal sarcoma | |
| SDHC | Gastrointestinal, renal, other | Paraganglioma and gastric stromal sarcoma | |
| SDHD | Gastrointestinal, renal, other | Cowden Syndrome 3; Paraganglioma and gastric stromal sarcoma | |
| SMAD4 | Colorectal, gastric | Juvenile Polyposis syndrome | |
| STK11 | Colorectal, endometrial, gastric, ovarian, breast, pancreatic | Peutz-Jeghers syndrome | |
| TP53 | Colorectal, breast, pancreatic, sarcomas, gastrointestinal, adrenocortical, leukemia | Li-Fraumeni syndrome | |
| Specimen Requirements | Blood (two 4ml EDTA tubes, lavender top) or Extracted DNA (3ug in EB buffer) or Buccal Swab or Saliva (kits available upon request) | ||
| Turnaround Time (TAT) | 2-3 weeks | ||
This will close in 0 seconds
| BreastDx Clear™ | |||
| Test Code: | 1250 | ||
| Test Description | BreastDx Clear is a multi-gene test that analyzes 16 breast cancer susceptibility genes. Although all women have some risk of developing breast and/or ovarian cancer at some point in their lives, having a mutation in one of the breast cancer susceptibility genes increases this risk. Men who have a mutation in one of the breast cancer susceptibility genes have an increased risk of breast, prostate, pancreatic, gastric and other cancer types. | ||
| Genes Tested | GENE | ASSOCIATED CANCER(S) | SYNDROME |
| ATM | Breast, pancreatic | Ataxia-telangiectasia (if both copies of the gene are mutated) | |
| BARD1 | Breast, ovarian | ||
| BRCA1 | Breast, ovarian, pancreatic, prostate, male breast | Hereditary Breast and Ovarian Cancer syndrome | |
| BRCA2 | Breast, ovarian, pancreatic, prostate, male breast, melanoma | Hereditary Breast and Ovarian Cancer syndrome; | |
| Fanconi anemia (if both copies of the gene are mutated) | |||
| BRIP1 | Ovarian, breast | Fanconi anemia (if both copies of the gene are mutated) | |
| CDH1 | Breast, gastric, colorectal | Hereditary Diffuse Gastric Cancer | |
| CHEK2 | Breast, colorectal | ||
| FANCC | Breast | Fanconi anemia (if both copies of the gene are mutated) | |
| MRE11A | Ovarian, breast | Ataxia-telangiectasia-like Syndrome (if both copies of the gene are mutated) | |
| NBN | Breast, melanoma, prostate | Nijmegen breakage syndrome (if both copies of the gene are mutated) | |
| PALB2 | Breast, ovarian, pancreatic, male breast | Fanconi anemia (if both copies of the gene are mutated) | |
| PTEN | Breast, uterine, colorectal, thyroid, kidney | Cowden Syndrome / PTEN Hamartoma Tumor Syndrome | |
| RAD51C | Breast, ovarian | Fanconi anemia (if both copies of the gene are mutated) | |
| RAD51D | Breast, ovarian | ||
| STK11 | Breast, ovarian, colorectal, gastric, pancreatic | Peutz-Jeghers Syndrome | |
| TP53 | Breast, brain, sarcomas, gastrointestinal, adrenocortical, leukemia | Li-Fraumeni Syndrome | |
| Specimen Requirements | Blood (two 4ml EDTA tubes, lavender top) or Extracted DNA (3ug in EB buffer) or Buccal Swab or Saliva (kits available upon request) | ||
| Turnaround Time (TAT) | 2-3 weeks | ||
This will close in 0 seconds
| ColoDx Clear™ | |||
| Test Code: | 1251 | ||
| Test Description | Colorectal cancer is the fourth most common type of cancer diagnosed in the United States and the second leading cause of cancer-related deaths in the country. ColoDx Clear is a multi-gene test focused on hereditary colon cancer syndromes. Pathogenic variants (mutations) in high-risk colorectal cancer genes are associated with several hereditary cancer syndromes and increase the risk of cancer in many organs. |
||
| Genes Tested | GENE | ASSOCIATED CANCER(S) | SYNDROME |
| APC | Colorectal, pancreatic and other | Familial Adenomatous Polyposis syndrome, Gardner syndrome, and Turcot syndrome | |
| BMPR1A | Colorectal, gastric | Juvenile Polyposis syndrome | |
| EPCAM | Colorectal, gastric, endometrial, ovarian | Lynch (Hereditary non-polyposis colon cancer) syndrome | |
| MLH1 | Colorectal, gastric, endometrial, ovarian | Lynch (Hereditary non-polyposis colon cancer) syndrome | |
| MSH2 | Colorectal, gastric, endometrial, ovarian | Lynch (Hereditary non-polyposis colon cancer) syndrome | |
| MSH6 | Colorectal, endometrial | Lynch (Hereditary non-polyposis colon cancer) syndrome | |
| MUTYH | Colorectal | MUTYH-associated Polyposis syndrome | |
| PMS2 | Colorectal, endometrial, gastric, ovarian | Lynch (Hereditary non-polyposis colon cancer) syndrome | |
| POLD1 | Colorectal, endometrial | Familial Adenomatous Polyposis syndrome | |
| POLE | Colorectal, gastrointestinal | Familial Adenomatous Polyposis syndrome | |
| PTEN | Colorectal, endometrial, breast, melanoma | Cowden syndrome | |
| SMAD4 | Colorectal, gastric | Juvenile Polyposis syndrome | |
| STK11 | Colorectal, endometrial, gastric, ovarian, breast, pancreatic | Peutz-Jeghers syndrome | |
| TP53 | Colorectal, breast, pancreatic and other | Li-Fraumeni syndrome | |
| Specimen Requirements | Blood (two 4ml EDTA tubes, lavender top) or Extracted DNA (3ug in EB buffer) or Buccal Swab or Saliva (kits available upon request) | ||
| Turnaround Time (TAT) | 2-3 weeks | ||
This will close in 0 seconds
| ProstateDx Clear™ | |
| Test Code: | 1257 |
| Test Description: | The ProstateDx Clear™ Panel examines genes associated with an increased risk for prostate cancer. This test includes both well-established prostate cancer susceptibility genes, as well as candidate genes with limited evidence of an association with prostate cancer. |
| Genes Tested: | ATM, BRCA1, BRCA2, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, NBN, PALB2, PMS2, TP53 |
| Specimen Requirements | Blood (two 4ml EDTA tubes, lavender top) or Extracted DNA (3ug in EB buffer) or Buccal Swab or Saliva (kits available upon request) |
| Turnaround Time (TAT) | 2-3 weeks |
This will close in 0 seconds
